529 related articles for article (PubMed ID: 25668622)
1. Improving selection criteria for lung cancer screening. The potential role of emphysema.
Sanchez-Salcedo P; Wilson DO; de-Torres JP; Weissfeld JL; Berto J; Campo A; Alcaide AB; Pueyo J; Bastarrika G; Seijo LM; Pajares MJ; Pio R; Montuenga LM; Zulueta JJ
Am J Respir Crit Care Med; 2015 Apr; 191(8):924-31. PubMed ID: 25668622
[TBL] [Abstract][Full Text] [Related]
2. Lung cancer screening: fourteen year experience of the Pamplona early detection program (P-IELCAP).
Sanchez-Salcedo P; Berto J; de-Torres JP; Campo A; Alcaide AB; Bastarrika G; Pueyo JC; Villanueva A; Echeveste JI; Lozano MD; García-Velloso MJ; Seijo LM; García J; Torre W; Pajares MJ; Pío R; Montuenga LM; Zulueta JJ
Arch Bronconeumol; 2015 Apr; 51(4):169-76. PubMed ID: 25641356
[TBL] [Abstract][Full Text] [Related]
3. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S;
Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736
[TBL] [Abstract][Full Text] [Related]
4. Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score.
de-Torres JP; Wilson DO; Sanchez-Salcedo P; Weissfeld JL; Berto J; Campo A; Alcaide AB; García-Granero M; Celli BR; Zulueta JJ
Am J Respir Crit Care Med; 2015 Feb; 191(3):285-91. PubMed ID: 25522175
[TBL] [Abstract][Full Text] [Related]
5. Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?
Pinsky PF; Berg CD
J Med Screen; 2012 Sep; 19(3):154-6. PubMed ID: 23060474
[TBL] [Abstract][Full Text] [Related]
6. Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy.
Young RP; Duan F; Chiles C; Hopkins RJ; Gamble GD; Greco EM; Gatsonis C; Aberle D
Am J Respir Crit Care Med; 2015 Nov; 192(9):1060-7. PubMed ID: 26199983
[TBL] [Abstract][Full Text] [Related]
7. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.
Ten Haaf K; Jeon J; Tammemägi MC; Han SS; Kong CY; Plevritis SK; Feuer EJ; de Koning HJ; Steyerberg EW; Meza R
PLoS Med; 2017 Apr; 14(4):e1002277. PubMed ID: 28376113
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Selection Criteria for Low-Dose Lung Screening CT Among Asian Ethnic Groups in Taiwan: From Mass Screening to Specific Risk-Based Screening for Non-Smoker Lung Cancer.
Wu FZ; Huang YL; Wu CC; Tang EK; Chen CS; Mar GY; Yen Y; Wu MT
Clin Lung Cancer; 2016 Sep; 17(5):e45-e56. PubMed ID: 27133540
[TBL] [Abstract][Full Text] [Related]
9. Application of risk prediction models to lung cancer screening: a review.
Tammemägi MC
J Thorac Imaging; 2015 Mar; 30(2):88-100. PubMed ID: 25692785
[TBL] [Abstract][Full Text] [Related]
10. Performance of the cancer risk management model lung cancer screening module.
Flanagan WM; Evans WK; Fitzgerald NR; Goffin JR; Miller AB; Wolfson MC
Health Rep; 2015 May; 26(5):11-8. PubMed ID: 25993046
[TBL] [Abstract][Full Text] [Related]
11. Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease.
Tanner NT; Dai L; Bade BC; Gebregziabher M; Silvestri GA
Am J Respir Crit Care Med; 2017 Sep; 196(5):602-608. PubMed ID: 28722466
[TBL] [Abstract][Full Text] [Related]
12. CT screening for lung cancer: alternative definitions of positive test result based on the national lung screening trial and international early lung cancer action program databases.
Yip R; Henschke CI; Yankelevitz DF; Smith JP
Radiology; 2014 Nov; 273(2):591-6. PubMed ID: 24955929
[TBL] [Abstract][Full Text] [Related]
13. Baseline characteristics of participants in the randomized national lung screening trial.
; Aberle DR; Adams AM; Berg CD; Clapp JD; Clingan KL; Gareen IF; Lynch DA; Marcus PM; Pinsky PF
J Natl Cancer Inst; 2010 Dec; 102(23):1771-9. PubMed ID: 21119104
[TBL] [Abstract][Full Text] [Related]
14. The performance of NLST screening criteria in Asian lung cancer patients.
Kumar V; Becker K; Zheng HX; Huang Y; Xu Y
BMC Cancer; 2015 Nov; 15():916. PubMed ID: 26582178
[TBL] [Abstract][Full Text] [Related]
15. Emphysema detected by lung cancer screening with low-dose spiral CT: prevalence, and correlation with smoking habits and pulmonary function in Japanese male subjects.
Omori H; Nakashima R; Otsuka N; Mishima Y; Tomiguchi S; Narimatsu A; Nonami Y; Mihara S; Koyama W; Marubayashi T; Morimoto Y
Respirology; 2006 Mar; 11(2):205-10. PubMed ID: 16548907
[TBL] [Abstract][Full Text] [Related]
16. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.
Pinsky PF; Gierada DS; Black W; Munden R; Nath H; Aberle D; Kazerooni E
Ann Intern Med; 2015 Apr; 162(7):485-91. PubMed ID: 25664444
[TBL] [Abstract][Full Text] [Related]
17. Identifying high-risk individuals for lung cancer screening: Going beyond NLST criteria.
Fu M; Travier N; Martín-Sánchez JC; Martínez-Sánchez JM; Vidal C; Garcia M;
PLoS One; 2018; 13(4):e0195441. PubMed ID: 29621354
[TBL] [Abstract][Full Text] [Related]
18. The neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers for lung cancer development.
Sanchez-Salcedo P; de-Torres JP; Martinez-Urbistondo D; Gonzalez-Gutierrez J; Berto J; Campo A; Alcaide AB; Zulueta JJ
Lung Cancer; 2016 Jul; 97():28-34. PubMed ID: 27237024
[TBL] [Abstract][Full Text] [Related]
19. Selection criteria for lung-cancer screening.
Tammemägi MC; Katki HA; Hocking WG; Church TR; Caporaso N; Kvale PA; Chaturvedi AK; Silvestri GA; Riley TL; Commins J; Berg CD
N Engl J Med; 2013 Feb; 368(8):728-36. PubMed ID: 23425165
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the impact of varied compliance to lung cancer screening recommendations using a microsimulation model.
Han SS; Erdogan SA; Toumazis I; Leung A; Plevritis SK
Cancer Causes Control; 2017 Sep; 28(9):947-958. PubMed ID: 28702814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
